Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat Care
<b>Objectives</b>: Piperacillin/tazobactam (P/T) is a broad-spectrum β-lactam antibiotic frequently used in outpatient parenteral antimicrobial therapy programs (OPAT). We aim to compare the clinical outcomes of P/T treatment in two models of OPAT care in order to maximize the utilization of health...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2025-11-01
|
| シリーズ: | Pharmaceutics |
| 主題: | |
| オンライン・アクセス: | https://www.mdpi.com/1999-4923/17/11/1429 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
